Gossamer Bio (GOSS) Return on Sales (2024 - 2026)
Gossamer Bio (GOSS) posted quarterly Return on Sales of 0.03% for Q1 2026, up 1.0% year-over-year from 0.03% in Q1 2025, and up 13.71% quarter-over-quarter from 0.03% in Q4 2025.
Gossamer Bio (GOSS) Return on Sales (2024 - 2026) Analysis & Trends
Gossamer Bio's Return on Sales history runs 3 years deep, the most recent figure standing at 0.03% for Q1 2026.
- In Q1 2026, Return on Sales rose 1.0% year-over-year to 0.03%; the TTM figure through Mar 2026 stood at 0.03% (down 3.0% YoY), while the FY2025 annual figure was 0.04%, down 3.0% from the prior year.
- Return on Sales for Q1 2026 stood at 0.03%, up from 0.03% in the prior quarter.
- The five-year high for Return on Sales was 0.02% in Q4 2024, with the low at 0.04% in Q1 2025.
- The 3-year median for Return on Sales is 0.03% (2024), against an average of 0.02%.
- The sharpest annual moves came in 2025 and 2026: Return on Sales dropped 6 bps in 2025, then rose 1 bps in 2026.
- Gossamer Bio's Return on Sales stood at 0.02% in 2024, then plunged by 252 bps to 0.03% in 2025, then gained by 14 bps to 0.03% in 2026.
- Business Quant data shows GOSS's Return on Sales at 0.03% in Q1 2026, 0.03% in Q4 2025, and 0.04% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.04 Bn | 130.19 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 85.58 Bn | 77.59 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 64.52 Bn | 59.34 Bn | 1.37 Bn | 0.00% |
| 4 | Moderna | 56.52 Bn | 51.38 Bn | 52.00 Mn | -0.05% |
| 5 | BeOne Medicines | 42.04 Bn | 36.94 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 30.67 Bn | 27.36 Bn | 992.69 Mn | 0.00% |
| 7 | Insmed | 27.27 Bn | 26.11 Bn | 358.27 Mn | 0.00% |
| 8 | BioNTech SE | 27.14 Bn | 8.75 Bn | 668.28 Mn | 0.00% |
| 9 | Royalty Pharma | 27.12 Bn | 26.28 Bn | - | 0.00% |
| 10 | Gossamer Bio | 50.02 Mn | -7.01 Mn | - | -0.03% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.03% |
| Mar 31, 2026 | -0.03% |
| Dec 31, 2025 | -0.03% |
| Sep 30, 2025 | -0.04% |
| Jun 30, 2025 | -0.03% |
| Mar 31, 2025 | -0.04% |
| Dec 31, 2024 | 0.02% |
| Sep 30, 2024 | -0.03% |
| Jun 30, 2024 | 0.01% |